Additionally, it has been suggested IL-19 might act as an assessment tool for psoriasis and atopic dermatitis patients (43), and along with IL-23/IL-17, has strengthened its role as a biomarker for chronic inflammatory disorders (44). This evidence concerns the gene IL19 and atopic eczema.